Published in CA Cancer J Clin on January 22, 2007
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol (2008) 3.54
MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett (2009) 1.92
Cellular traction stresses increase with increasing metastatic potential. PLoS One (2012) 1.50
U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality. Cancer Epidemiol Biomarkers Prev (2011) 1.31
Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States. PLoS One (2015) 0.96
A new method to evaluate the completeness of case ascertainment by a cancer registry. Cancer Causes Control (2008) 0.94
The RAS/mitogen activated protein (MAP) kinase pathway in melanoma biology and therapeutics. Biologics (2007) 0.77
Prioritizing US Cervical Cancer Prevention With Results From a Geospatial Model. J Glob Oncol (2016) 0.75
Trends in Lung and Bronchus, Prostate, Female Breast, and Colon and Rectum Cancers Incidence and Mortality in Oklahoma and the United States from 1999 to 2012. J Okla State Med Assoc (2016) 0.75
Utility of death certificate data in predicting cancer incidence. Am J Ind Med (2013) 0.75
Survival and recurrence rate after treatment for primary spinal sarcomas. J Korean Neurosurg Soc (2013) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin (2011) 30.81
Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71
Cancer statistics, 2005. CA Cancer J Clin (2005) 25.65
Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med (2005) 16.70
Cancer statistics, 2004. CA Cancer J Clin (2004) 15.72
Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin (2012) 14.47
Cancer statistics, 2003. CA Cancer J Clin (2003) 13.46
Colorectal cancer statistics, 2014. CA Cancer J Clin (2014) 12.86
Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin (2004) 12.55
The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med (2007) 12.23
Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin (2014) 11.09
Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst (2011) 10.29
Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst (2002) 9.45
Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer (2004) 9.24
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36
Trends in the leading causes of death in the United States, 1970-2002. JAMA (2005) 8.20
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst (2008) 8.14
International variation in prostate cancer incidence and mortality rates. Eur Urol (2012) 8.04
Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res (2006) 7.67
Breast cancer statistics, 2013. CA Cancer J Clin (2013) 7.35
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst (2003) 7.06
Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst (2002) 6.87
Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer (2007) 6.84
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol (2012) 6.37
Breast cancer statistics, 2011. CA Cancer J Clin (2011) 6.12
Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer (2002) 6.08
Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin (2007) 5.67
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer (2009) 5.55
Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin (2007) 5.31
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
Cancer mortality in the United States by education level and race. J Natl Cancer Inst (2007) 4.77
Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin (2006) 4.73
Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer (2006) 4.71
Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med (2009) 4.60
International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev (2009) 4.49
Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer (2013) 4.24
Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin (2012) 4.13
The global burden of cancer: priorities for prevention. Carcinogenesis (2009) 3.73
Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin (2014) 3.59
Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin (2012) 3.58
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55
Estimating average annual per cent change in trend analysis. Stat Med (2009) 3.54
Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev (2013) 3.40
Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res (2007) 3.23
Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev (2009) 3.08
Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. J Natl Cancer Inst (2002) 3.04
Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomarkers Prev (2009) 3.04
Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med (2005) 3.02
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.77
Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst (2006) 2.66
The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines. Cancer (2012) 2.61
Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol (2011) 2.58
Estimating average annual percent change for disease rates without assuming constant change. Biometrics (2006) 2.51